1 - Introduction

This Funding Opportunity Announcement (FOA) encourages applications from research partnerships formed by academic and industrial investigators, to accelerate the translation of technologies, methods, assays or devices, and/or systems for preclinical or clinical molecular diagnosis or in vitro imaging that are designed to solve a targeted cancer problem.

2 - Scope

The proposed systems may include molecular diagnosis, molecular imaging or related research resources. Funding may be requested to enhance, adapt, optimize, validate, and otherwise translate the following examples, among others: (a) current commercially supported systems, (b) next-generation systems, (c) quality assurance and quality control, (d) validation and correlation studies, (e) quantitative imaging, and (f) related research resources. Because applications should be translational in scope, this FOA defines innovation as a coherent translational plan to deliver emerging or new capabilities for preclinical or clinical use that are not yet broadly employed in preclinical or clinical settings. In addition, innovation may be considered as delivery of a new capability to end users. The partnership on each application should establish an inter-disciplinary, multi-institutional research team to work in strategic alliance to implement a coherent strategy to develop and translate their system to solve their chosen cancer problem. This FOA will support clinical trials that test functionality, optimize, and validate the performance of the proposed translational work. This FOA does not intend to support either actual commercial production or basic research projects that do not emphasize translation.

3 - Duration

The scope of the proposed project should determine the project period. The maximum period is 5 years.

4 - Budget

Application budgets are not limited but need to reflect the actual needs of the proposed project.

5 - Eligibility

Non-domestic (non-U.S.) Entities (Foreign Institutions) are  eligible to apply.

Non-domestic (non-U.S.) components of U.S. Organizations are  eligible to apply.

6 - Deadline

* VHIR deadline is 23/02/2015

* The official deadline is 06/03/2015

7 - More information

More information can be found at: LINK